4.5 Editorial Material

What Does the Food and Drug Administration Safety and Innovation Act Mean For You?

期刊

OCULAR SURFACE
卷 11, 期 3, 页码 206-209

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jtos.2013.04.002

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Ophthalmology

How many vs. how much

Gary D. Novack

OCULAR SURFACE (2019)

Editorial Material Ophthalmology

Eyes on New Product Development

Gary D. Novack

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Editorial Material Ophthalmology

Eyes on New Product Development

Gary D. Novack

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Editorial Material Ophthalmology

Eyes on New Product Development

Gary D. Novack

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Letter Medicine, General & Internal

Orphan drugs

Andrea Messori, Francesco Attanasio, Sabrina Trippoli, Roberto Banfi

LANCET (2019)

Article Ophthalmology

Real world evidence for pharmaceuticals

Gary D. Novack

OCULAR SURFACE (2019)

Article Ophthalmology

Retinal Detachment: Patient Perspective and Electronic Health Records

Gary D. Novack, Michele C. Lim

AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)

Editorial Material Ophthalmology

Eyes on New Product Development

Gary D. Novack

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Editorial Material Ophthalmology

Eyes on New Product Development

Gary D. Novack

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Editorial Material Ophthalmology

One More Time: Generic Solutions are the Same as Branded

Gary D. Novack

OPHTHALMOLOGY GLAUCOMA (2023)

Review Ophthalmology

US Regulatory Approval of a Drug-Eluting Contact Lens

Gary D. D. Novack

EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2023)

Article Ophthalmology

Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution

Victor H. Gonzalez, David L. Wirta, Martin Uram, Audrey Schupp, Michelle Widmann, Gary Novack

Summary: The aim of this study was to develop a new topical ocular anesthetic with good bioavailability in anterior segment tissues. AG-920 (articaine ophthalmic solution) in unit-dose, nonpreserved blow-fill-seal containers was used. Two Phase 3 studies involving 240 healthy subjects showed that AG-920 provided rapid onset of local anesthesia with no major safety issues.

CLINICAL OPHTHALMOLOGY (2023)

Article Ophthalmology

Phase I/II, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension

Paul J. Hartman, David L. Cooke, Henry H. Hsu, Jeanette Stewart, Kengo Sumi, Yoko Yoshida, Hiroyoshi Hidaka, Gary D. Novack

Summary: “This study aimed to evaluate the efficacy and tolerability of an H-1337 ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension. The results showed that the H-1337 ophthalmic solution significantly lowered intraocular pressure and was well tolerated.”

OPHTHALMOLOGY GLAUCOMA (2023)

Article Ophthalmology

Efficacy and safety of netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma and ocular hypertension

Jefferson D. Berryman, Gary D. Novack

EXPERT REVIEW OF OPHTHALMOLOGY (2019)

暂无数据